PrenaTest®
Europe’s first NIPT
starting from 129 Euro
PrenaTest®
Europe’s first non-invasive prenatal test (NIPT)
Starting from 129 Euro
Non-invasive blood test (NIPT) for the examination of fetal genetic material from maternal blood – safe for your unborn child
PraenaRhD Test
The prenatal rhesus test
starting from 149 Euro
PraenaRhD Test
The non-invasive prenatal rhesus test
starting from 149 Euro
Non-invasive prenatal RhD genotyping from maternal blood
COVID-19 Testing
High volume COVID-19 testing by quantitative Real-time PCR
Eurofins LifeCodexx has set up a dedicated testing platform for sarsCoV-2 detection
PrenaTest®– Your advantage for more knowledge
Identify risks. Optimize care.
- Many years of experience – First NIPT in Europe launched in 2012
- Since 2012: laboratory analysis in Constance, Germany
- Fast & safe test with high accuracy, harmless to the unborn child
- Comprehensive – determination of trisomies and many other chromosomal disorders in the genetic material of the unborn child
- Inexpensive & often reimbursed by health insurers
- Experienced, comprehensive scientific support – quick answers, prompt delivery
- NIPT Pioneer – first NIPT on the European market
- Since 2012 – laboratory analysis in Constance, Germany
- Long-term collaborative partnership with the medical profession
- NIPT innovations – first qPCR-based NIPT worldwide with CE marking
- German company with a high level of awareness
- Most affordable trisomy 21 test
200.000 PrenaTest® analysed in Constance, Germany
PraenaRhD
The prenatal rhesus test
If you are rhesus-negative, you can now have the rhesus factor of your unborn child determined using the PraenaRhD from Eurofins LifeCodexx. If your child is rhesus-negative, you can decide together with your doctor if you wish to forgo the anti-D prophylaxis.
Eurofins LifeCodexx
Pioneering non-invasive prenatal testing in Europe
In Germany, since 2010, we have developed prenatal genetic tests of the highest quality which allow women to be informed at an early point in their pregnancy and make independent decisions. In 2012 the PrenaTest® was launched on the market as Europe’s first NIPT. It has now become firmly established in many gynecological practices as a reliable, fast and safe test method. Since the start of 2018, LifeCodexx has belonged to Eurofins Scientific, a leading international laboratory group.
In Germany, NIPT will be covered by health insurance – we submitted the applications
How to reach us
Do you require information about our tests? Then be sure to read our answers to the most frequently asked questions. Of course we are happy to answer any further questions you may have. Regardless of whether you contact us by email, letter, online or by phone.